19.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Innoviva Inc Borsa (INVA) Ultime notizie
Synergy Asset Management LLC Invests $1.85 Million in Innoviva, Inc. $INVA - MarketBeat
Avoiding Lag: Real-Time Signals in (INVA) Movement - Stock Traders Daily
Innoviva’s Stock Under the Microscope: Is INVA Quietly Setting Up Its Next Move? - AD HOC NEWS
Innoviva joins elite list of stocks with 95-plus composite rating - MSN
Pacer Advisors Inc. Sells 48,889 Shares of Innoviva, Inc. $INVA - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - MSN
Is Innoviva Inc stock in correction or buying zoneJuly 2025 Reactions & Community Trade Idea Sharing Platform - moha.gov.vn
Despite Lower Earnings Than Five Years Ago, Innoviva (NASDAQ:INVA) Investors Are up 65% Since Then - 富途牛牛
Innoviva (INVA): Valuation Check After FDA Approval of First-in-Class NUZOLVENCE Antibiotic - Sahm
Innoviva (NASDAQ:INVA) Share Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Is Innoviva Inc a good long term investmentMarket Sentiment Report & Small Investment Portfolio - earlytimes.in
December 2026 Options Now Available For Innoviva (INVA) - Nasdaq
How Investors May Respond To Innoviva (INVA) Winning FDA Approval For First-In-Class Gonorrhea Drug - Sahm
H.C. Wainwright Lifts PT on Innoviva (INVA) to $46 From $45, Keeps a Buy Rating - Finviz
Technical Reactions to INVA Trends in Macro Strategies - Stock Traders Daily
Will Innoviva Inc. stock attract ESG investorsTrade Exit Report & Daily Profit Maximizing Trade Tips - Улправда
Will Innoviva Inc. (HVE) stock justify high valuation2025 Volatility Report & Weekly Watchlist for Consistent Profits - Улправда
Will Innoviva Inc. (HVE) stock recover faster than industryJuly 2025 Short Interest & High Return Trade Guides - Улправда
12 Small Cap Stocks to Buy with Huge Upside Potential - Insider Monkey
Can Innoviva Inc. stock deliver surprise earnings beatMarket Growth Summary & Low Drawdown Momentum Ideas - Улправда
Aug Fed Impact: How Innoviva Inc. (HVE) stock compares with tech leadersInsider Selling & Short-Term High Return Ideas - Улправда
Can Innoviva Inc. (HVE) stock deliver double digit returnsJuly 2025 Weekly Recap & Daily Stock Trend Reports - Улправда
Is Innoviva Still Attractive Around $20 After Strong Multi Year Share Price Gains? - Yahoo Finance
How Innoviva Inc. stock responds to policy changesQuarterly Portfolio Review & Free Safe Entry Trade Signal Reports - DonanımHaber
Why Innoviva Inc. stock is in analyst buy zoneWeekly Risk Summary & Stock Portfolio Risk Control - DonanımHaber
Is Innoviva Inc. stock positioned for digital transformationJuly 2025 Patterns & Long-Term Capital Growth Strategies - DonanımHaber
Can Innoviva Inc. stock deliver sustainable ROENew Guidance & Low Risk Entry Point Guides - DonanımHaber
Profit Recap: Can Innoviva Inc. (HVE) stock deliver double digit returnsJuly 2025 Catalysts & Weekly Stock Performance Updates - Улправда
Will Innoviva Inc. stock see PE expansion2025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
Innoviva, Inc. (NASDAQ:INVA) Receives $38.60 Average Target Price from Analysts - Defense World
HC Wainwright & Co. Maintains Innoviva (INVA) Buy Recommendation - Nasdaq
INVA: HC Wainwright & Co. Maintains Buy Rating and Raises Price Target | INVA Stock News - GuruFocus
Innoviva announces Lancet publication of 'positive' Zoliflodacin Phase 3 data - MSN
U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents - BioSpace
Innoviva Specialty Therapeutics announces FDA approval of Nuzolvence - MSN
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Innoviva (INVA): Revisiting Valuation After a Strong Multi‑Year Share Price Run - Sahm
US FDA approves Innoviva’s oral antibiotic for gonorrhea - WTAQ
US FDA approves Innoviva's oral antibiotic for gonorrhea - Reuters
Innoviva (NASDAQ: INVA) gets FDA approval for single-dose oral antibiotic NUZOLVENCE for gonorrhea - Stock Titan
Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea - BioSpace
Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 - PharmiWeb.com
Trading the Move, Not the Narrative: (INVA) Edition - Stock Traders Daily
Innoviva, Inc. $INVA Shares Bought by Marshall Wace LLP - MarketBeat
State Board of Administration of Florida Retirement System Cuts Stake in Innoviva, Inc. $INVA - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):